多发性硬化诊断和治疗中国专家共识(2018版)

[1] 干扰素β－1b治疗385例多发性硬化患者的回顾性研究 [J]. 中华神经科杂志, 2015, 48 (09) : 781 - 785

[2] ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : 96 - 120

[3] Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria[J] . Alan J Thompson,Brenda L Banwell,Frederik Barkhof,William M Carroll,Timothy Coetzee,Giancarlo Comi,Jorge Correale,Franz Fazekas,Massimo Filippi,Mark S Freedman,Kazuo Fujihara,Steven L Galetta,Hans Peter Hartung,Ludwig Kappos,Fred D Lublin,Ruth Ann Marrie,Aaron E Miller,David H Miller,Xavier Montalban,Ellen M Mowry,Per Soelberg Sorensen,Mar Tintoré,Anthony L Traboulsee,Maria Trojano,Bernard M J Uitdehaag,Sandra Vukusic,

[4] Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial[J] . Aaron E Miller,Jerry S Wolinsky,Ludwig Kappos,Giancarlo Comi,Mark S Freedman,Tomas P Olsson,Deborah Bauer,Myriam Benamor,Philippe Truffinet,Paul W O’Connor.Lancet Neurology . 2014 (10)

[5] Defining the clinical course of multiple sclerosis: The 2013 revisions[J] . Fred D. Lublin,Stephen C. Reingold,Jeffrey A. Cohen,Gary R. Cutter,Per Soelberg S?rensen,Alan J. Thompson,Jerry S. Wolinsky,Laura J. Balcer,Brenda Banwell,Frederik Barkhof,Bruce Bebo,Peter A. Calabresi,Michel Clanet,Giancarlo Comi,Robert J. Fox,Mark S. Freedman,Andrew D. Goodman,Matilde Inglese,Ludwig Kappos,Bernd C. Kieseier,John A. Lincoln,Catherine Lubetzki,Aaron E. Miller,Xavier Montalban,Paul W. O?Connor,John Petkau

[6] Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial[J] . Christian Confavreux,Paul O’Connor,Giancarlo Comi,Mark S Freedman,Aaron E Miller,Tomas P Olsson,Jerry S Wolinsky,Teresa Bagulho,Jean-Luc Delhay,Deborah Dukovic,Philippe Truffinet,Ludwig Kappos.Lancet Neurology . 2014 (3)

[7] Novel Immunomodulatory Approaches for the Management of Multiple Sclerosis [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 (01) : 32 - 44

[8] Consensus guidelines for the diagnosis and treatment of multiple sclerosis [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (06) : 611 - 621

[9] Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone [J]. NEUROLOGY, 2011, 77 (21) : 1887 - 1895

[10] Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology[J] . Neurology . 2010 (18)

[1] 干扰素β－1b治疗385例多发性硬化患者的回顾性研究 [J]. 中华神经科杂志, 2015, 48 (09) : 781 - 785

[2] ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : 96 - 120

[3] Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria[J] . Alan J Thompson,Brenda L Banwell,Frederik Barkhof,William M Carroll,Timothy Coetzee,Giancarlo Comi,Jorge Correale,Franz Fazekas,Massimo Filippi,Mark S Freedman,Kazuo Fujihara,Steven L Galetta,Hans Peter Hartung,Ludwig Kappos,Fred D Lublin,Ruth Ann Marrie,Aaron E Miller,David H Miller,Xavier Montalban,Ellen M Mowry,Per Soelberg Sorensen,Mar Tintoré,Anthony L Traboulsee,Maria Trojano,Bernard M J Uitdehaag,Sandra Vukusic,

[4] Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial[J] . Aaron E Miller,Jerry S Wolinsky,Ludwig Kappos,Giancarlo Comi,Mark S Freedman,Tomas P Olsson,Deborah Bauer,Myriam Benamor,Philippe Truffinet,Paul W O’Connor.Lancet Neurology . 2014 (10)

[5] Defining the clinical course of multiple sclerosis: The 2013 revisions[J] . Fred D. Lublin,Stephen C. Reingold,Jeffrey A. Cohen,Gary R. Cutter,Per Soelberg S?rensen,Alan J. Thompson,Jerry S. Wolinsky,Laura J. Balcer,Brenda Banwell,Frederik Barkhof,Bruce Bebo,Peter A. Calabresi,Michel Clanet,Giancarlo Comi,Robert J. Fox,Mark S. Freedman,Andrew D. Goodman,Matilde Inglese,Ludwig Kappos,Bernd C. Kieseier,John A. Lincoln,Catherine Lubetzki,Aaron E. Miller,Xavier Montalban,Paul W. O?Connor,John Petkau

[6] Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial[J] . Christian Confavreux,Paul O’Connor,Giancarlo Comi,Mark S Freedman,Aaron E Miller,Tomas P Olsson,Jerry S Wolinsky,Teresa Bagulho,Jean-Luc Delhay,Deborah Dukovic,Philippe Truffinet,Ludwig Kappos.Lancet Neurology . 2014 (3)

[7] Novel Immunomodulatory Approaches for the Management of Multiple Sclerosis [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 (01) : 32 - 44

[8] Consensus guidelines for the diagnosis and treatment of multiple sclerosis [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (06) : 611 - 621

[9] Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone [J]. NEUROLOGY, 2011, 77 (21) : 1887 - 1895

[10] Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology[J] . Neurology . 2010 (18)